Global Point-of-Care Testing (POCT) Market By Product,By Prescription Mode, By Distribution Channel, By End User, By Geography- Trends and Forecast to 2024
Global Point-of-Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request for Sample @ databridgemarketresearch.com/reque…_campaign=Shubham
The major factors driving the market for Point-Of-Care Testing market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place, and enhanced patient compliance are also driving the growth for the point-of-care testing market.On the hand, high cost, stringent regulatory framework, product recalls and reluctance from the industry towards changing the existing normsare some of the factors which may hinder the growth of the market.
The global point-of-care testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.
On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.In 2017, blood glucose testing kits segment is expected to dominate the market with a share of around 27.0% and is expected to continue this trend till 2024.
Browse Full Report @ databridgemarketresearch.com/repor…_campaign=Shubham
Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. The OTC testing is projected to witness higher growth rate of 8.9% during the forecast period to reach a value of USD 12.8 billion by 2024.
On the basis of distribution channel, the market is segmented into direct tenders and retail. In 2017, the direct tender market is expected to dominate the market with a share of 64.0% in the forecast period 2017-2024.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal).
Also, clinic is segmented into physicians’ clinic and diagnostic clinic.In 2017, the hospitalmarket is expected to dominate the market with a share of around 33.0% in the forecast period 2017-2024.
Request for TOC: databridgemarketresearch.com/toc/?…_campaign=Shubham
Based on geography the market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
In 2017, North America is expected to dominate the market.
The Global Point Of Care Testing Market Report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. The report includes market shares of prefilled syringes market for global, Europe, North America, Asia Pacific and South America.
Access Report: databridgemarketresearch.com/repor…_campaign=Shubham
Some of the major players operating in this market are
- F.Hoffmann-La Roche Ltd
- Siemens AG
- Abbott Laboratories, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Johnson & Johnson
- Alere Inc.
- Instrumentation Laboratory
- PTS Diagnostics
- Abaxis, Inc.
- Accriva Diagnostics
- OPTI Medical
- Sienco, Inc.
- Alpha Scientific
- AccuBioTech Co., Ltd.
- ACON Laboratories, Inc.
- Acrongenomics, Inc.
- bioMérieux SA
- Biomerica, Inc.
- Atlas Genetics Ltd.
- Alfa Scientific Designs, Inc.
- Bio-Rad Laboratories, Inc.
- Medica Corporation
- Nova Biomedica
Inquire Report @ databridgemarketresearch.com/inqui…_campaign=Shubham
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: